Assuntos
Dermatofibrossarcoma/patologia , Neoplasias Cutâneas/patologia , Pigmentação da Pele , Biomarcadores Tumorais/análise , Biópsia , Pré-Escolar , Dermatofibrossarcoma/química , Dermatofibrossarcoma/cirurgia , Humanos , Imuno-Histoquímica , Masculino , Neoplasias Cutâneas/química , Neoplasias Cutâneas/cirurgiaAssuntos
Centros Médicos Acadêmicos , Esgotamento Profissional/epidemiologia , Dermatologistas/psicologia , Relaxamento/psicologia , Tolerância ao Trabalho Programado/psicologia , Adulto , Fatores Etários , Idoso , Estudos Transversais , Feminino , Humanos , Relações Interprofissionais , Masculino , Pessoa de Meia-Idade , Relações Médico-Paciente , Gravidez , Medição de Risco , Fatores Sexuais , Estados UnidosRESUMO
Lyme disease is the most common tick-borne disease in the United States and has a multitude of systemic effects. Infrequently, however, Lyme disease is seen to cause liver dysfunction. Dermatologists should be aware that early, disseminated borreliosis can present with multiple erythema migrans plaques and hepatitis.
Assuntos
Hepatite/complicações , Doença de Lyme/complicações , Adulto , Eritema Migrans Crônico/complicações , Humanos , Doença de Lyme/diagnóstico , Doença de Lyme/tratamento farmacológico , Doença de Lyme/patologia , Masculino , Coxa da Perna/patologiaRESUMO
Patients often are apprehensive about starting biologic medications for their psoriasis. Typical fears include anxiety regarding possible side effects and reluctance in accepting their proven efficacy. In this study, we aimed to evaluate patients' willingness to take a biologic medication for their psoriasis if presented with clinical trial evidence, an anecdote, or both. A prospective online survey study was performed in 222 patients with psoriasis. Patients were randomized to receive clinical trial evidence of a biologic medication's efficacy and safety, an anecdote of a single patient's positive experience, or both. Responses were recorded on a 10-point Likert scale and evaluated using the Kruskal-Wallis test followed by Dunn test. Results indicated that presenting an anecdote-alone or in combination with clinical trial evidence-may be an effective way to improve patients' willingness to take a biologic medication for psoriasis.